top of page

BMO Capital Markets’ Evan Seigerman joins BiotechTV for Analyst Thursdays

Evan Seigerman gives his take on biotech and discusses the Medicare negotiation list, Lilly, Amgen, Skyscraper-01, Structure Therapeutics, Disc Medicine, Replimune, and other upcoming catalysts.




Comentarios


Join the BiotechTV mailing list

Thanks for subscribing!

bottom of page